Corsano Health B.V.
9
1
1
4
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 45/100
0.0%
0 terminated/withdrawn out of 9 trials
100.0%
+13.5% vs industry average
0%
0 trials in Phase 3/4
25%
1 of 4 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (9)
HEARTS in Sync + CardioWatch 287-2
Role: collaborator
Validation of a Vital Signs Monitoring Wristband
Role: lead
Multi-Centre Based Study Recognition of Atrial Fibrillation With the Corsano CardioWatch 287-2 System
Role: lead
Comparative Evaluation of Body Temperature Measurement Using the CardioWatch 287-2 in an Intensive Care Setting.
Role: lead
FRAILTY Classification Algorithm for the Corsano CARDIOWATCH 287-2: a Development and Validation Study
Role: lead
Blood Pressure Treatment by the Corsano CardioWatch 287-2 Evaluation Study
Role: lead
Older Adults Exercising On Time
Role: collaborator
REmote CArdiac MOnitoring by the Corsano CardioWatch 287-2 Evaluation Study
Role: lead
Accuracy of CardioWatch 287-2 During Profound Hypoxia
Role: lead
All 9 trials loaded